Across Protocol vs Symbiosis — how do they compare? Across Protocol trades at Rp742.19 (market cap Rp505,3M, Rp188,8M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Across Protocol is far larger — about 14.8× Symbiosis's market cap, and Across Protocol 's circulating supply is 716,5M / 1B ACX (72%) versus 97M / 99,5M SIS (98%) for Symbiosis. Which is the better fit depends on your goals — on Pluang, investors hold Across Protocol for 57 Days and Symbiosis for 13 Days on average.
| ACX | SIS | |
|---|---|---|
Market Cap | Rp505,3M | Rp34,08M |
Volume (24h) | Rp188,8M | Rp2,71M |
Circulating Supply | 716,5M / 1B ACX (72%) | 97M / 99,5M SIS (98%) |
Typical Hold Time | 57 Days | 13 Days |
Signals from Pluang's Aura AI — not financial advice
Across Protocol (ACX) is trading at Rp728.43 with a market cap of Rp505.3M, showing bearish technical signals with 15 sell signals versus 3 buys. The token is near its pivot point of Rp714, with key support at Rp665 and resistance at Rp751. With 72% of max supply in circulation and average hold time of 57 days, the token shows moderate distribution. No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with bearish technical dominance. Key opportunity lies in oversold RSI conditions suggesting potential bounce, while major risks include low liquidity and concentrated sell pressure. Investors should monitor support levels closely and watch for any protocol developments that could shift momentum.
Symbiosis (SIS) shows limited market activity with a modest market cap of Rp34.08M and high circulating supply utilization at 98%. The token exhibits a short average hold time of 13 days, suggesting active trading but potentially weak long-term holder confidence. No recent protocol updates or significant ecosystem developments have been recorded, indicating stagnant project momentum.
Overall outlook remains cautious due to low market cap and limited fundamental catalysts. Key opportunities include potential ecosystem growth if development resumes, while major risks involve low liquidity, high volatility typical of small-cap tokens, and regulatory uncertainty in the crypto space.
Across (ACX) is a cross-chain token bridge secured by UMA's optimistic oracle. Designed for capital efficiency, ACX features a single liquidity pool, competitive relayer options, and a no-slippage fee model. Because its oracle verifies transfers optimistically, ACX is able to process cross-chain transfers quickly.
Read more on ACX →Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →